Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Collaborative Appoints New President

NEW YORK, Jan 5 – Genomics Collaborative, a SNP-detection company, said Friday it has appointed Michael Dougherty as president and chief operating officer.

Dougherty was previously president and CEO of biotech company Magainin Pharmaceuticals, where he will remain non-executive chairman of the board.

“We view Michael’s arrival as another step toward CGI positioning itself to develop genomic based products,” CEO Michael Pellini said in a statement.

  Based in Cambridge, Mass., Genomics Collaborative is a privately held company that recently raised $36 million from investors including Invesco Private Capital, Oracle Partners, AFTC Funds, and the Economic Development Board of Singapore.

The company has partnership agreements with companies such as Lynx Therapeutics, Gene Logic, Qiagen, and Genometrix.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.